Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ovarian Suppression: Early Menopause and Late Effects.
Molinelli C, Jacobs F, Nader-Marta G, Borea R, Scavone G, Ottonello S, Fregatti P, Villarreal-Garza C, Bajpai J, Kim HJ, Puglisi S, de Azambuja E, Lambertini M. Molinelli C, et al. Curr Treat Options Oncol. 2024 Apr;25(4):523-542. doi: 10.1007/s11864-024-01190-8. Epub 2024 Mar 13. Curr Treat Options Oncol. 2024. PMID: 38478329 Free PMC article. Review.
LuciA-15 - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genes.
Petracci FE, Villarreal-Garza C, Argañaraz F, Abuin GG, Peñaloza J, Flores MA, Piazzoni L, Riggi C, Fabiano L, González L, Cieplinski B, Rivero S, Korbenfeld E, Mandó P. Petracci FE, et al. Ecancermedicalscience. 2023 Nov 21;17:1634. doi: 10.3332/ecancer.2023.1634. eCollection 2023. Ecancermedicalscience. 2023. PMID: 38414929 Free PMC article.
Prognosis impact and clinical findings in renal cancer patients: comparative analysis between public and private health coverage in a cross-sectional and multicenter context.
Barrera-Juarez E, Halun-Trevino AN, Ruelas-Martinez M, Madero-Frech A, Camacho-Trejo V, Estrada-Bujanos M, Bojorquez D, Uribe-Montoya J, Rodriguez-Covarrubias F, Villarreal-Garza C. Barrera-Juarez E, et al. Among authors: villarreal garza c. Cancer Causes Control. 2024 Nov 8. doi: 10.1007/s10552-024-01891-3. Online ahead of print. Cancer Causes Control. 2024. PMID: 39514146
Sexual Function and Satisfaction in Young Women with Breast Cancer: A Five-Year Prospective Study.
Ferrigno Guajardo A, Vaca-Cartagena BF, Mesa-Chavez F, Platas A, Fonseca A, Cruz-Ramos M, Miaja Avila M, Rodriguez AL, Cabrera-Galeana P, Mohar A, Villarreal-Garza C. Ferrigno Guajardo A, et al. Among authors: villarreal garza c. JNCI Cancer Spectr. 2024 Nov 6:pkae111. doi: 10.1093/jncics/pkae111. Online ahead of print. JNCI Cancer Spectr. 2024. PMID: 39504463
Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women.
Chavarri-Guerra Y, Ferrigno-Guajardo A, Villarreal-Garza C, Martinez-Cannon BA, Abugattas-Saba J, Fontaine AC, Horcasitas DJ, Mora-Alferez P, Unzeitig GW, Brown S, Mohar-Betancourt A, Nehoray B, Del Toro-Valero A, Daneri-Navarro A, Ganschow P, Komenaka I, Rodriguez Y, Gutierrez Seymour G, Valdez L, Blazer KR, Ellis S, Weitzel JN. Chavarri-Guerra Y, et al. Among authors: villarreal garza c. JCO Glob Oncol. 2024 Oct;10:e2400097. doi: 10.1200/GO.24.00097. Epub 2024 Oct 31. JCO Glob Oncol. 2024. PMID: 39481075
Evaluation of a Proteomics-Guided Protein Signature for Breast Cancer Detection in Breast Tissue.
Moreno-Ulloa A, Zárate-Córdova VL, Ramírez-Sánchez I, Cruz-López JC, Perez-Ortiz A, Villarreal-Garza C, Díaz-Chávez J, Estrada-Mena B, Antonio-Aguirre B, López-Almanza PX, Lira-Romero E, Estrada-Mena FJ. Moreno-Ulloa A, et al. Among authors: villarreal garza c. J Proteome Res. 2024 Nov 1;23(11):4907-4923. doi: 10.1021/acs.jproteome.4c00295. Epub 2024 Oct 16. J Proteome Res. 2024. PMID: 39412830
Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated Factors.
Mesa-Chavez F, Chavarri-Guerra Y, López-Covarrubias AV, Mayette-Villanueva AE, Ruiz-Cruz S, Del Río-Martínez CJ, Bermudez-Barrientos CG, Samayoa-Mateos A, Manzanares-Castellanos AG, Moreno-Jaime B, Vega-Morales D, Tenorio-Torres JA, Villarreal-Garza C. Mesa-Chavez F, et al. Among authors: villarreal garza c. Clin Breast Cancer. 2024 Aug;24(6):501-509.e2. doi: 10.1016/j.clbc.2024.04.012. Epub 2024 May 3. Clin Breast Cancer. 2024. PMID: 38789360
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Schettini F, Blondeaux E, Molinelli C, Bas R, Kim HJ, Di Meglio A, Bernstein Molho R, Linn SC, Pogoda K, Carrasco E, Punie K, Agostinetto E, Lopetegui-Lia N, Phillips KA, Toss A, Rousset-Jablonski C, Acheritogaray M, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Puglisi F, Vasconcelos de Matos L, Mariño M, Teixeira L, Graffeo R, Rognone A, Chirco A, Antone N, Abdou Y, Marhold M, Božović-Spasojević I, Cortés Salgado A, Carmisciano L, Bruzzone M, Curigliano G, Prat A, Lambertini M. Schettini F, et al. Among authors: villarreal garza c. Cancer. 2024 Aug 15;130(16):2746-2762. doi: 10.1002/cncr.35323. Epub 2024 May 16. Cancer. 2024. PMID: 38752572 Free article.
161 results